A good show of confidence in management and hopefully continues to be a safe pair of hands. I know from reading previously TK wants to really grow the company to its full potential rather than sell in a takeover.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%